Disease eradication combined with immune restoration represent the “holy grail” of treatment for CLL, according to Australian haematologists. Writing in Leukemia & Lymphoma, Dr Sasanka Handunnetti and Professor Con Tam from the Peter MacCallum Cancer Centre, said the immune impacts of Bruton tyrosine kinase (BTK) inhibitors and possibly selective BCL-2 inhibitors might help achieve that ...
Cure in CLL requires disease control plus immune restoration
By Mardi Chapman
11 Sep 2020